top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)

From Traders Agency | Ad

AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple. Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now… And could soon shoot to the moon, handing early investors a windfall.

Click here now for the full details of this stock that’s set to rocket in the AI revolution…

OKYO Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 40.46%

Insider Buying (Last 12 Months): $25,005.00

Insider Selling (Last 12 Months): $0.00

OKYO Pharma Insider Trading History Chart

OKYO Pharma Share Price & Price History

^$1.36

▲ +0.01 (0.74%)

As of 07/26/2024 01:00 AM ET

Days: 30 | 90 | 365

I’m giving you the name of this investment for free

From Porter & Company | Ad

This key unlocks a new pathway to wealth that has been kept hidden from you for decades. In my new documentary I will provide you with all the details of this one-of-a-kind investment.

Let me explain in this new documentary video

OKYO Pharma Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
9/15/2023	John P Brancaccio	Director	Buy	16,670	$1.50	$25,005.00	16,670

I’m giving you the name of this investment for free

From Porter & Company | Ad

This key unlocks a new pathway to wealth that has been kept hidden from you for decades. In my new documentary I will provide you with all the details of this one-of-a-kind investment.

Let me explain in this new documentary video

SEC Filings (Institutional Ownership Changes) for OKYO Pharma (NASDAQ:OKYO)

2.97% of OKYO Pharma stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

OKYO Pharma Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company	Details
11/7/2023	Barclays PLC	25,000	$46K	0.0%	N/A	0.087%

Data available starting January 2016

OKYO Pharma Limited, a clinical-stage biopharmaceutical company, engages in developing therapeutics for patients suffering from inflammatory eye diseases and ocular pain in the United Kingdom. Its lead preclinical product candidate is OK-101, which is in Phase II clinical trials for the treatment of dry eye disease. The company is also developing OK-201, a bovine adrenal medulla, lipidated-peptide preclinical analogue candidate for the treatment of neuropathic chronic pain. The company was incorporated in 2007 and is headquartered in London, the United Kingdom.

Read More

Today's Range

Now: $1.36

$1.35

$1.47

50 Day Range

MA: $1.37

$1.13

$1.68

52 Week Range

Now: $1.36

$1.09

$3.07

Volume

28,641 shs

Average Volume

95,511 shs

Market Capitalization

$39.24 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of OKYO Pharma?: OKYO Pharma's top insider shareholders include:
John P Brancaccio (Director)
Learn More about top insider investors at OKYO Pharma.

top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)

From Traders Agency | Ad

AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple. Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now… And could soon shoot to the moon, handing early investors a windfall.

Click here now for the full details of this stock that’s set to rocket in the AI revolution…